These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38862897)

  • 1. Targeted analysis of Ubiquitin-Specific Peptidase (USP8) in a population of Iranian people with Cushing's disease and a systematic review of the literature.
    Hashemi-Madani N; Cheraghi S; Emami Z; Mehrjardi AZ; Kaynama MR; Khamseh ME
    BMC Endocr Disord; 2024 Jun; 24(1):86. PubMed ID: 38862897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
    Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
    Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
    Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas.
    Martins CS; Camargo RC; Coeli-Lacchini FB; Saggioro FP; Moreira AC; de Castro M
    Horm Metab Res; 2020 Feb; 52(2):117-123. PubMed ID: 32053843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's disease: towards precision medicine.
    Kaiser UB
    Cell Res; 2015 Jun; 25(6):649-50. PubMed ID: 25930709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent gain-of-function USP8 mutations in Cushing's disease.
    Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
    Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.
    Sesta A; Cassarino MF; Terreni M; Ambrogio AG; Libera L; Bardelli D; Lasio G; Losa M; Pecori Giraldi F
    Neuroendocrinology; 2020; 110(1-2):119-129. PubMed ID: 31280266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease.
    Faucz FR; Tirosh A; Tatsi C; Berthon A; Hernández-Ramírez LC; Settas N; Angelousi A; Correa R; Papadakis GZ; Chittiboina P; Quezado M; Pankratz N; Lane J; Dimopoulos A; Mills JL; Lodish M; Stratakis CA
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2836-2843. PubMed ID: 28505279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
    Theodoropoulou M; Reincke M; Fassnacht M; Komada M
    Eur J Endocrinol; 2015 Oct; 173(4):M73-83. PubMed ID: 26012588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
    Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
    Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas.
    Losa M; Mortini P; Pagnano A; Detomas M; Cassarino MF; Pecori Giraldi F
    Endocrine; 2019 Feb; 63(2):240-246. PubMed ID: 30315484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
    Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
    J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours.
    Miao H; Wang L; Gong F; Duan L; Wang L; Yao Y; Feng M; Deng K; Wang R; Xiao Y; Ling Q; Zhu H; Lu L
    Clin Endocrinol (Oxf); 2024 Jul; 101(1):32-41. PubMed ID: 38691659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
    Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
    Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Cushing's disease: an update.
    Perez-Rivas LG; Reincke M
    J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel
    Uzilov AV; Cheesman KC; Fink MY; Newman LC; Pandya C; Lalazar Y; Hefti M; Fowkes M; Deikus G; Lau CY; Moe AS; Kinoshita Y; Kasai Y; Zweig M; Gupta A; Starcevic D; Mahajan M; Schadt EE; Post KD; Donovan MJ; Sebra R; Chen R; Geer EB
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001602. PubMed ID: 28487882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status.
    Bujko M; Kober P; Boresowicz J; Rusetska N; Paziewska A; Dąbrowska M; Piaścik A; Pękul M; Zieliński G; Kunicki J; Bonicki W; Ostrowski J; Siedlecki JA; Maksymowicz M
    Eur J Endocrinol; 2019 Dec; 181(6):615-627. PubMed ID: 31581124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.
    Abraham AP; Pai R; Beno DL; Chacko G; Asha HS; Rajaratnam S; Kapoor N; Thomas N; Chacko AG
    Endocrine; 2022 Feb; 75(2):549-559. PubMed ID: 34664215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
    Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
    Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.
    Albani A; Perez-Rivas LG; Tang S; Simon J; Lucia KE; Colón-Bolea P; Schopohl J; Roeber S; Buchfelder M; Rotermund R; Flitsch J; Thorsteinsdottir J; Herms J; Stalla G; Reincke M; Theodoropoulou M
    Endocr Relat Cancer; 2022 Aug; 29(8):503-511. PubMed ID: 35686696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.